A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study
Evaluating the Safety and Efficacy of Efruxifermin in Non-Cirrhotic
Subjects with Nonalcoholic Steatohepatitis (NASH)
Please contact us for more information or to learn if you are eligible to participate.
